A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
Status:
Completed
Trial end date:
2015-12-04
Target enrollment:
Participant gender:
Summary
This study is conducted in Japan. The aim of the study is to evaluate the efficacy of
somatropin (Norditropin®) on adult height (cm) in patients with achondroplasia /
hypochondroplasia enrolled in the GH-1941 study (NCT01516229).